ANPRM International Pricing Index Model for Medicare Part B Drugs
The Centers for Medicare & Medicaid Services (CMS) is committed to implementing President Trump’s blueprint to lower drug costs and reduce out-of-pocket costs for patients. In line with the policies discussed in the President’s blueprint, the CMS is soliciting public comments on potential options we may consider for testing changes to payment for certain separately payable Part B drugs and biologicals (“drugs”).
Newsroom Fact SheetMedicare Advantage Prior Authorization and Step Therapy for Part B Drugs
Today, the Centers for Medicare & Medicaid Services (CMS) introduced much-needed competition and negotiation into the market for physician-administered and other Part B medications that will result in better deals and lower drug costs for patients. As part of the agency’s ongoing activities to deliver on President Trump’s promises outlined in his American Patients First Blueprint, CMS will provide Medicare Advantage plans the option of applying step therapy for physician-administered and other Part B drugs in a way that lowers costs and improves the quality of care for Medicare beneficiaries.
Newsroom Fact SheetSpeech: Medicare Remarks by CMS Administrator Seema Verma at the Commonwealth Club of California
I’d like to talk to you about things on which we all agree, like the future of our healthcare system, and Medicare. And if we have time we can touch quickly on world peace before we all leave.
Newsroom Press ReleaseCMS Empowers Patients and Ensures Site-Neutral Payment in Proposed Rule
Outpatient Prospective Payment System (OPPS) & Ambulatory Surgical Center (ASC) proposed rule advances CMS commitment to increasing transparency and lowering drug prices.
Newsroom Press ReleaseCMS proposes Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System changes for 2019 (CMS-1695-P)
On July 25, 2018, CMS proposed changes that would encourage site-neutral payment between sites of services and make healthcare prices more transparent for patients so that they can be more informed about out-of-pocket costs.
Newsroom Fact SheetMedicare Trustees Report shows lower spending projections for Medicare Part D
Today, the Medicare Board of Trustees released their annual report for Medicare’s two separate trust funds -- the Hospital Insurance (HI) Trust Fund and the Supplementary Medical Insurance (SMI) Trust Fund.
Newsroom Press ReleaseSpeech: Remarks by CMS Administrator Seema Verma at the Pharmacy Quality Alliance Annual Meeting
Good afternoon, it’s a pleasure to be with you today. Pharmacists are on the front lines of patient care and have keen insight to the issues that patients face. We appreciate your hard work, and we look forward to working with you on a goal that I’m sure we share – ensuring that all patients can access their medications at an affordable price.
Newsroom Fact SheetCMS Unveils Enhanced “Drug Dashboards” to Increase Transparency on Drug Prices
Today, the Centers for Medicare & Medicaid Services released a redesigned version of the Drug Spending Dashboards. For the first time, the dashboards include year-over-year information on drug pricing and highlight which manufactures have been increasing their prices.
Newsroom Press ReleaseDrug Spending Information Products Fact Sheet
Today, the Centers for Medicare & Medicaid Services announced the release of updated information products that provide greater transparency on drug spending in the Medicare and Medicaid programs.
Newsroom Fact SheetSpeech: Remarks by CMS Administrator Seema Verma at the American Hospital Association Annual Membership Meeting
Good morning, and thank you for that kind introduction. I also want to thank the American Hospital Association for the invitation. For those of you that don’t know me, I spent the early days of my career at a public hospital.
Newsroom Fact Sheet